Health

Qnexa Anti-Obesity Drug a Poor Substitute for Diet, Exercise (ContributorNetwork)

ContributorNetwork – COMMENTARY | The Food and Drug Administration has approved the anti-obesity drug Qnexa for weight loss. Qnexa, an anticonvulsant plus appetite suppressant cocktail, has risks, says the LA Times. The FDA says being fat is a bigger threat to health than those issues, though.

Continued here:
Qnexa Anti-Obesity Drug a Poor Substitute for Diet, Exercise
(ContributorNetwork)

Health

Contraceptives Work Well in Obese Women, But Hormone Levels Lower (HealthDay)

HealthDay – THURSDAY, Feb. 23 (HealthDay News) — Hormonal contraceptives appear to thwart pregnancy just as well in overweight and obese women as those of normal weight despite markedly lower pregnancy-prevention hormone levels among heavier females, a group of reproductive experts said.

Read the rest here: 
Contraceptives Work Well in Obese Women, But Hormone Levels
Lower
(HealthDay)

Health

FDA Panel Recommends Approval for Weight-Loss Drug Qnexa (ContributorNetwork)

ContributorNetwork – A weight-loss pill from Vivus Inc. has become the first such drug recommended for approval by the FDA in more than 13 years. An advisory panel voted in favor of approving the pill, known as Qnexa, by a margin of 20-2 on Wednesday, according to MSNBC. The FDA has until April 17 to formally approve Qnexa for use in the United States.

View original here: 
FDA Panel Recommends Approval for Weight-Loss Drug Qnexa
(ContributorNetwork)

Health

FDA Advisers Back Weight-Loss Drug Qnexa (HealthDay)

HealthDay – WEDNESDAY, Feb. 22 (HealthDay News) — A U.S. Food and Drug Administration advisory panel gave its blessing Wednesday to a highly anticipated weight loss pill that had been rejected by health advisers once before.

Originally posted here: 
FDA Advisers Back Weight-Loss Drug Qnexa
(HealthDay)

Health

U.S. advisers back experimental obesity pill (Reuters)

Reuters – Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years.

More:
U.S. advisers back experimental obesity pill
(Reuters)

Health

FDA panel gives nod to Vivus obesity drug (Reuters)

Reuters – An experimental obesity drug from Vivus Inc won a U.S. panel’s support on Wednesday, raising hopes regulators would approve a weight-loss pill for the first time in 13 years.

Read more: 
FDA panel gives nod to Vivus obesity drug
(Reuters)

Health

FDA Weighs Fate of Qnexa for Weight Loss, Again (HealthDay)

HealthDay – TUESDAY, Feb. 21 (HealthDay News) — The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects.

Here is the original: 
FDA Weighs Fate of Qnexa for Weight Loss, Again
(HealthDay)

Health

New Weight-Loss Equation: Researchers Determine Key Calorie Cutoff (LiveScience.com)

LiveScience.com – VANCOUVER — Weight loss is not as simple as eating less and exercising more, and for those who struggle to shed the pounds, a new equation may offer some help.

Excerpt from: 
New Weight-Loss Equation: Researchers Determine Key Calorie Cutoff
(LiveScience.com)

Health

Obesity rates rise, threaten health in OECD nations (Reuters)

Reuters – More people in developed countries are overweight or obese than ever before, dooming them to years of ill health, pushing up healthcare costs and piling more pressure on health systems, a report by the OECD found on Tuesday.

Here is the original: 
Obesity rates rise, threaten health in OECD nations
(Reuters)

Health

Fructose not linked to extra weight gain: report (Reuters)

Reuters – A little extra simple sugar in your diet probably won’t make you pack on the pounds — as long as you cut down on other carbs to make up for it, a new analysis of past studies suggests.

See the rest here:
Fructose not linked to extra weight gain: report
(Reuters)

« Previous Page — Next Page »